Estradiol dienantate
http://dbpedia.org/resource/Estradiol_dienantate an entity of type: Thing
Estradiol dienanthate (EDE), sold under the brand names Climacteron among others, is a long-acting estrogen medication which was previously used in menopausal hormone therapy for women and to suppress lactation in women. It was formulated in combination with estradiol benzoate (EB), a short-acting estrogen, and testosterone enanthate benzilic acid hydrazone (TEBH), a long-acting androgen/anabolic steroid. EDE has not been made available for medical use alone. The medication, in combination with EB and TEBH, was given by injection into muscle once or at regular intervals, for instance once every 6 weeks.
rdf:langString
rdf:langString
Estradiol dienantate
xsd:integer
50790495
xsd:integer
1120786023
xsd:integer
32
xsd:integer
7732
xsd:integer
145199
rdf:langString
DB13955
xsd:integer
48
rdf:langString
Estradiol dienanthate molecule ball.png
rdf:langString
[-3-heptanoyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] heptanoate
xsd:integer
4
xsd:integer
165688
rdf:langString
CCCCCCCO[C@H]1CC[C@@H]2[C@@]1C
xsd:integer
1
rdf:langString
OVAHZPTYWMWNKO-CAHAWPIUSA-N
rdf:langString
Estradiol dienantate; EDE; EDEn; E2-EDN; Estradiol diheptanoate; Estra-1,3,5-triene-3,17β-diol 3,17β-diheptanoate
rdf:langString
Climacteron, Amenose, Lactimex, Lactostat
xsd:integer
65
xsd:integer
250
rdf:langString
Estradiol dienanthate (EDE), sold under the brand names Climacteron among others, is a long-acting estrogen medication which was previously used in menopausal hormone therapy for women and to suppress lactation in women. It was formulated in combination with estradiol benzoate (EB), a short-acting estrogen, and testosterone enanthate benzilic acid hydrazone (TEBH), a long-acting androgen/anabolic steroid. EDE has not been made available for medical use alone. The medication, in combination with EB and TEBH, was given by injection into muscle once or at regular intervals, for instance once every 6 weeks. Side effects of EDE include breast tenderness, breast enlargement, nausea, headache, and fluid retention. EDE is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. It is an estrogen ester and a prodrug of estradiol in the body. Because of this, it is considered to be a natural and bioidentical form of estrogen. EDE was first described by 1959. It was previously available in Canada and Germany but was discontinued by 2005. The medication is no longer available in any form.
xsd:nonNegativeInteger
16523
rdf:langString
Climacteron, Amenose, Lactimex, Lactostat (all combinations)
xsd:string
7732-97-0
xsd:string
DB13955
xsd:string
65C72P1860
xsd:string
165688
